Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oleogel-S-10 vs placebo in mild to moderate actinic keratoses of face and head
2008-002632-15Phase 2Completed
- Sponsor
- Birken AG
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing Oleogel-S-10 with Placebo (2 arms). Primary endpoints: Clinical clearance of all treated actinic keratoses and Histologically controlled complete clearance of the marker actinic keratosis. Started Jul 2008; status: completed.
02
Drugs
Birch bark extract
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2008-002632-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002632-15.